Impact of Hyponatremia on Muscle Strength, Gait and Cognitive Function
NCT04020926 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2020-06-25
Summary
In this study patients with hyponatremia, defined as a serum sodium \< 126 mmol/L on admission to the hospital will be tested for muscular power by use of a hand grip dynamometer, for cognitive function by use of the Montreal-Cognitive-Assessment and gait stability by use of the Tinetti test. The tests will be performed on admission as well es after correction of hyponatremia.
Conditions
Sponsors & Collaborators
-
Bürgerspital Solothurn
lead OTHER
Principal Investigators
-
Gregor Lindner, M.D. · Dept. of Internal and Emergency Medicine, Buergerspital Solothurn, Switzerland
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar Hyponatremia
NCT00541944 ·Status: COMPLETED
-
Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT01909336 ·Status: COMPLETED ·Phase: PHASE3
-
HYPONATREMIA IN COVID-19 PATIENTS
NCT04493268 ·Status: COMPLETED
-
Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges
NCT06408077 ·Status: RECRUITING ·Phase: NA
-
Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery
NCT07273630 ·Status: RECRUITING ·Phase: NA
-
Variation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized Children
NCT01251770 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia
NCT01110655 ·Status: UNKNOWN ·Phase: NA
-
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
NCT01240668 ·Status: COMPLETED
-
Maintenance Intravenous Fluids in Children
NCT00621348 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients
NCT02912299 ·Status: COMPLETED
-
Exploring Water-free Sodium Storage
NCT06872645 ·Status: RECRUITING ·Phase: NA
-
The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia
NCT01748331 ·Status: UNKNOWN ·Phase: NA
-
Hydrochloorthiazide and Hypernatriaemie
NCT01974739 ·Status: COMPLETED ·Phase: NA
-
Sodium Management in Acute Neurological Injury
NCT01558843 ·Status: COMPLETED
-
Low Sodium Diet in Oligohydramnios Assigned for Conservative Management
NCT03815968 ·Status: UNKNOWN ·Phase: NA
-
Hyponatremia Volume Status Analysis by Point-of-care Ultrasound
NCT06013800 ·Status: ACTIVE_NOT_RECRUITING
-
Hypertonic Saline Solution in Heart Failure
NCT00555685 ·Status: COMPLETED ·Phase: PHASE2
-
0,9% NaCl Effect on Kidney Function and Glycocalyx in Patients Operated on for Primary Hiparthrosis
NCT02528448 ·Status: UNKNOWN ·Phase: PHASE4
-
0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children
NCT00632775 ·Status: COMPLETED ·Phase: PHASE3
-
Mortality and Neurologic Outcomes in Rapid vs. Slow Hyponatremia Correction
NCT06675591 ·Status: COMPLETED
-
Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion
NCT00696605 ·Status: COMPLETED
-
Reexamining Hypotonic Intravenous Fluid Use
NCT02667977 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
NCT01227512 ·Status: TERMINATED ·Phase: PHASE3
-
Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension
NCT01520207 ·Status: COMPLETED ·Phase: PHASE2
-
Best Solution Identification to Prevent Hyperchloremia Combinations of Sodium Chloride and Sodium Acetate IV Fluids Along With Standard of Care Treatment in Acute Stroke Patients
NCT05869565 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3